Skip to content

Clinical trials

Phase 2 Sepsis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 2 Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20091
20101
20121
20151
20191
20211
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
Ottawa Hospital Research Institute2
Agennix1
Artisan Pharma, Inc.1
Eli Lilly and Company1
GlaxoSmithKline1
Leading BioSciences, Inc1
Novartis Pharmaceuticals1
Unity Health Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis15
Shock, Septic6
Infections3
Acute Kidney Injury2
Shock2
Systemic Inflammatory Response Syndrome2
Coronavirus Infections1
Critical Illness1
Disseminated Intravascular Coagulation1
Edema1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.